ATE56357T1 - Arzneimittel mit schwerloeslichem wirkstoff sowie verfahren zu dessen herstellung. - Google Patents
Arzneimittel mit schwerloeslichem wirkstoff sowie verfahren zu dessen herstellung.Info
- Publication number
- ATE56357T1 ATE56357T1 AT85303824T AT85303824T ATE56357T1 AT E56357 T1 ATE56357 T1 AT E56357T1 AT 85303824 T AT85303824 T AT 85303824T AT 85303824 T AT85303824 T AT 85303824T AT E56357 T1 ATE56357 T1 AT E56357T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- active substance
- soluble active
- medicinal products
- partly soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848414221A GB8414221D0 (en) | 1984-06-04 | 1984-06-04 | Unit dosage form |
EP85303824A EP0164967B1 (de) | 1984-06-04 | 1985-05-30 | Arzneimittel mit schwerlöslichem Wirkstoff sowie Verfahren zu dessen Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE56357T1 true ATE56357T1 (de) | 1990-09-15 |
Family
ID=10561913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85303824T ATE56357T1 (de) | 1984-06-04 | 1985-05-30 | Arzneimittel mit schwerloeslichem wirkstoff sowie verfahren zu dessen herstellung. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4717569A (de) |
EP (1) | EP0164967B1 (de) |
JP (1) | JPS611613A (de) |
KR (1) | KR860000067A (de) |
AT (1) | ATE56357T1 (de) |
AU (1) | AU578474B2 (de) |
CA (1) | CA1242646A (de) |
DE (1) | DE3579631D1 (de) |
DK (1) | DK164355C (de) |
ES (1) | ES8608865A1 (de) |
FI (1) | FI84783C (de) |
GB (1) | GB8414221D0 (de) |
GR (1) | GR851355B (de) |
IL (1) | IL75372A (de) |
MX (1) | MX161943A (de) |
NO (1) | NO166918C (de) |
NZ (1) | NZ212255A (de) |
PH (1) | PH22173A (de) |
PT (1) | PT80584B (de) |
ZA (1) | ZA854115B (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
GB2176999B (en) * | 1985-06-22 | 1989-07-12 | Stanley Stewart Davis | Sustained release medicament |
US4833133A (en) * | 1986-05-22 | 1989-05-23 | Sterling Drug Inc. | Method of regulating fertility in cattle using epostane |
US4870068A (en) * | 1986-05-22 | 1989-09-26 | Sterling Drug Inc. | Method of regulating fertility in swine using epostane |
JP2680614B2 (ja) * | 1988-08-01 | 1997-11-19 | 日清製粉株式会社 | ダナゾール組成物 |
JP2773895B2 (ja) * | 1989-04-25 | 1998-07-09 | 東京田辺製薬株式会社 | ダナゾール組成物 |
JP2542122B2 (ja) * | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | 球状核、球形顆粒およびその製造方法 |
EP0452862B1 (de) * | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung |
US5223268A (en) * | 1991-05-16 | 1993-06-29 | Sterling Drug, Inc. | Low solubility drug-coated bead compositions |
US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5573783A (en) * | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
US7863331B2 (en) * | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2795961B1 (fr) | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
JP3386052B2 (ja) * | 2001-02-13 | 2003-03-10 | トヨタ自動車株式会社 | ポンプ装置 |
GB2375958B (en) * | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2842736B1 (fr) * | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
GB2400554B (en) * | 2003-04-16 | 2007-04-18 | George Margetts | Treatment of angiotensin II-induced cardiovascular disease |
NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
ATE504288T1 (de) * | 2003-09-26 | 2011-04-15 | Alza Corp | Oros-push-stick für die kontrollierte abgabe von wirkstoffen |
JP5563731B2 (ja) * | 2003-09-26 | 2014-07-30 | アルザ・コーポレーシヨン | オピオイドおよび非オピオイド鎮痛薬の制御放出製剤 |
JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
US20060003002A1 (en) * | 2003-11-03 | 2006-01-05 | Lipocine, Inc. | Pharmaceutical compositions with synchronized solubilizer release |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
FR2885526B1 (fr) * | 2005-05-13 | 2007-07-27 | Flamel Technologies Sa | Medicament oral a base d'inhibiteur de pompe a protons |
US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
EP2018437A2 (de) * | 2006-05-02 | 2009-01-28 | Allozyne, Inc. | Mit nicht-natürlichen aminosäuren substituierte polypeptide |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
EP2257220B1 (de) * | 2008-03-13 | 2017-06-14 | Liebel-Flarsheim Company LLC | Fussbetätigte multifunktionssteuerung für bildgebungssystem |
US8883176B2 (en) | 2008-09-25 | 2014-11-11 | Isp Investments Inc. | Smooth, high solids tablet coating composition |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US20140030346A1 (en) * | 2010-12-27 | 2014-01-30 | Masashi Konishi | Disintegrable core particle for pharmaceutical preparation |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB742007A (en) * | 1953-04-01 | 1955-12-14 | Smith Kline & French Internat | Improvements in or relating to method of forming coated pharmaceutical pellets |
GB765086A (en) * | 1954-11-19 | 1957-01-02 | Smith Kline & French Internat | Anticholinergic preparation |
GB785262A (en) * | 1955-09-23 | 1957-10-23 | Smith Kline & French Internat | Improvements in or relating to hypotensive and sedative preparations |
GB844772A (en) * | 1956-04-19 | 1960-08-17 | Pfizer & Co C | Granular pharmaceutical compositions and process for preparing same |
US3328256A (en) * | 1963-05-27 | 1967-06-27 | William E Gaunt | Spherical beads and their production |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
AT336190B (de) * | 1974-07-23 | 1977-04-25 | Hurka Wilhelm | Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes |
GB1561301A (en) * | 1976-01-02 | 1980-02-20 | Beecham Group Ltd | Orally administrable pharmaceutical composition |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
FR2510582B1 (fr) * | 1981-07-30 | 1986-05-30 | Sipsy | Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
-
1984
- 1984-06-04 GB GB848414221A patent/GB8414221D0/en active Pending
-
1985
- 1985-05-24 US US06/738,104 patent/US4717569A/en not_active Expired - Fee Related
- 1985-05-30 EP EP85303824A patent/EP0164967B1/de not_active Expired - Lifetime
- 1985-05-30 DE DE8585303824T patent/DE3579631D1/de not_active Expired - Fee Related
- 1985-05-30 ZA ZA854115A patent/ZA854115B/xx unknown
- 1985-05-30 NZ NZ212255A patent/NZ212255A/xx unknown
- 1985-05-30 AT AT85303824T patent/ATE56357T1/de not_active IP Right Cessation
- 1985-05-31 PH PH32345A patent/PH22173A/en unknown
- 1985-05-31 IL IL75372A patent/IL75372A/xx unknown
- 1985-06-03 DK DK247485A patent/DK164355C/da not_active IP Right Cessation
- 1985-06-03 AU AU43237/85A patent/AU578474B2/en not_active Ceased
- 1985-06-03 ES ES543828A patent/ES8608865A1/es not_active Expired
- 1985-06-03 KR KR1019850003860A patent/KR860000067A/ko not_active Application Discontinuation
- 1985-06-03 CA CA000482998A patent/CA1242646A/en not_active Expired
- 1985-06-03 NO NO852226A patent/NO166918C/no unknown
- 1985-06-04 JP JP60121367A patent/JPS611613A/ja active Pending
- 1985-06-04 MX MX8263A patent/MX161943A/es unknown
- 1985-06-04 GR GR851355A patent/GR851355B/el unknown
- 1985-06-04 FI FI852236A patent/FI84783C/fi not_active IP Right Cessation
- 1985-06-04 PT PT80584A patent/PT80584B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK247485A (da) | 1985-12-05 |
NO166918B (no) | 1991-06-10 |
JPS611613A (ja) | 1986-01-07 |
FI852236A0 (fi) | 1985-06-04 |
GR851355B (de) | 1985-11-25 |
EP0164967A3 (en) | 1986-12-30 |
IL75372A (en) | 1989-08-15 |
DE3579631D1 (de) | 1990-10-18 |
ES8608865A1 (es) | 1986-07-16 |
CA1242646A (en) | 1988-10-04 |
NO852226L (no) | 1985-12-05 |
PT80584A (en) | 1985-07-01 |
PT80584B (pt) | 1987-09-18 |
AU4323785A (en) | 1985-12-12 |
AU578474B2 (en) | 1988-10-27 |
GB8414221D0 (en) | 1984-07-11 |
IL75372A0 (en) | 1985-09-29 |
EP0164967B1 (de) | 1990-09-12 |
MX161943A (es) | 1991-03-08 |
ES543828A0 (es) | 1986-07-16 |
FI84783C (fi) | 1992-01-27 |
EP0164967A2 (de) | 1985-12-18 |
DK164355B (da) | 1992-06-15 |
FI852236L (fi) | 1985-12-05 |
DK247485D0 (da) | 1985-06-03 |
DK164355C (da) | 1992-11-02 |
US4717569A (en) | 1988-01-05 |
ZA854115B (en) | 1986-01-29 |
FI84783B (fi) | 1991-10-15 |
NO166918C (no) | 1991-09-18 |
NZ212255A (en) | 1988-06-30 |
KR860000067A (ko) | 1986-01-25 |
PH22173A (en) | 1988-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE56357T1 (de) | Arzneimittel mit schwerloeslichem wirkstoff sowie verfahren zu dessen herstellung. | |
ATE66142T1 (de) | Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung. | |
NL188502C (nl) | Werkwijze voor het bereiden van fysiologisch verdraagbare polymeerdeeltjes die een biologisch actief materiaal bevatten en werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat dat dergelijke polymeerdeeltjes bevat en aldus verkregen gevormde therapeutische preparaten. | |
DE220143T1 (de) | Pharmazeutische zubereitungen von metoprolol mit kontrollierter wirkstoff abgabe, verfahren zu ihrer herstellung und verwendung dieser zubereitungen. | |
ATE73323T1 (de) | Arzneimittel in form einer einheitsdosis mit verzoegerter freisetzung sowie verfahren zu dessen herstellung. | |
DE122004000012I2 (de) | 20-Spiroxane und Analoge mit ge¦ffnetem Ring E, Verfahren zu ihrer Herstellung, sowie pharmazeutische Pr{parate davon | |
PT75497B (de) | Harnstoffderivate verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung | |
AU555512B2 (en) | New galenical administration form of metoclopramide, method for its preparation and medicament comprising this new form | |
AU3447184A (en) | New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions | |
ATE10634T1 (de) | Pyrazoloindazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung. | |
DE68906461T2 (de) | Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung. | |
ATE817T1 (de) | 2-(1-phenyl-2,5-cyclohexa dienyl)-aethylaminderivate, verfahren zu deren herstellung, deren verwendung als pharmazeutische wirkstoffe sowie diese enthaltende arzneimittel. | |
HK35184A (en) | Ethanolamine compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use | |
ATE3976T1 (de) | Substituierte 3-(1-pyrrolidinyl)-5-sulfamoylbenzoes[ure-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, die sie enthalten und verfahren zu deren herstellung. | |
LU84492A1 (de) | Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate | |
ATE23168T1 (de) | 11-beta-aryl-estradiene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
ZA817395B (en) | 1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application | |
ZA817559B (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application | |
ATE50579T1 (de) | Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen. | |
ATE22898T1 (de) | Gallensaeurederivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3481684D1 (de) | Therapeutische anwendung eines indandionderivats und pharmazeutische zusammensetzungen zu ihrer verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |